Vaccine in phase 3 trial said to be 90% effective

Brussels: The European Union said Monday that it was very close to signing a contract with drugs firms Pfizer and BioNTech for 300 million doses of a future new coronavirus vaccine.
"European science works!" declared Ursula von der Leyen, the president of the European Commission, congratulating the US and German companies after they claimed a breakthrough.
Sign up for the Daily Briefing
Get the latest news and updates straight to your inbox